phosphorylcholine and vorinostat

phosphorylcholine has been researched along with vorinostat in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, C; Dai, Y; Dent, P; Grant, S; Payne, SG; Rahmani, M; Reese, E; Spiegel, S1
Aherne, W; Atadja, P; Beloueche-Babari, M; Chung, YL; Griffiths, JR; Jackson, LE; Judson, IR; Kristeleit, R; Leach, MO; Troy, H; Workman, P1
Bojdani, E; Hou, P; Xing, M1
Liu, Z; Xing, M1
Brandes, AH; Eriksson, P; Izquierdo-Garcia, JL; Ronen, SM; Ward, CS1
Orlowski, RZ1
Jiang, W; Li, S; Li, X; Liang, H; Liu, H; Lu, L; Wang, Y; Zhan, M; Zhang, C; Zhao, Y1

Reviews

1 review(s) available for phosphorylcholine and vorinostat

ArticleYear
Novel agents for multiple myeloma to overcome resistance in phase III clinical trials.
    Seminars in oncology, 2013, Volume: 40, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunologic Factors; Indoles; Multiple Myeloma; Oligopeptides; Panobinostat; Phosphorylcholine; Piperidines; Proteasome Inhibitors; Pyridines; Remission Induction; Thalidomide; Thiazoles; Treatment Outcome; Vorinostat

2013

Other Studies

6 other study(ies) available for phosphorylcholine and vorinostat

ArticleYear
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
    Cancer research, 2005, Mar-15, Volume: 65, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Butyrates; Cell Growth Processes; Cell Line, Tumor; Ceramides; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Leukemia; MAP Kinase Signaling System; Mitochondria; Mitogen-Activated Protein Kinase 3; Phosphorylcholine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Vorinostat

2005
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts.
    Neoplasia (New York, N.Y.), 2008, Volume: 10, Issue:4

    Topics: Acetylation; Animals; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; HT29 Cells; Humans; Hydroxamic Acids; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Nuclear Magnetic Resonance, Biomolecular; Phosphorus Isotopes; Phosphorylcholine; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays

2008
Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:2

    Topics: Cell Line, Tumor; Gene Expression Regulation; Humans; Hydroxamic Acids; Intracellular Signaling Peptides and Proteins; Iodine Radioisotopes; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Symporters; Thyroid Gland; Thyroid Neoplasms; Thyrotropin; TOR Serine-Threonine Kinases; Vorinostat

2010
Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Diphenylamine; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Iodine Radioisotopes; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Signal Transduction; Sulfonamides; Symporters; Transcriptional Activation; Vorinostat

2012
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Choline; Enzyme Activation; Female; Gene Expression Regulation; Glycerylphosphorylcholine; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Magnetic Resonance Spectroscopy; MCF-7 Cells; Phosphorylcholine; Vorinostat

2013
Ultralong circulating choline phosphate liposomal nanomedicines for cascaded chemo-radiotherapy.
    Biomaterials science, 2019, Mar-26, Volume: 7, Issue:4

    Topics: Animals; Anthraquinones; Antineoplastic Agents; Cell Hypoxia; Chemoradiotherapy; Female; Liposomes; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Molecular Structure; Nanomedicine; Phosphorylcholine; Vorinostat

2019